You are here
Associate Professor Maree Hackett
Maree is a conjoint Associate Professor (course co-ordinator for MIPH 5127) within the Faculty of Medicine at The University of Sydney, Head of the Mental Health and Chronic Disease Program at The George Institute, Reader in Epidemiology at the University of Central Lancashire and holds a Doctor of Philosophy in Medicine from the University of Auckland.
Maree leads a program of research at The George Institute focusing on developing simple, cost effective strategies (which can be integrated with other secondary prevention strategies) to screen for and prevent depression and significantly improve the outcome for people with vascular disease.
Maree currently holds a National Heart Foundation Future Leader Fellowship (2014-2017) ‘Improving the identification and management of depression in people with cardiovascular disease’.
Some of Maree’s current projects include:
- NHMRC funded validation study of a culturally-specific measure to identify depression in Aboriginal and Torres Strait Islander people with or without chronic disease (2014-2016, CIA)
- NHMRC funded Australasian, multi-centre, randomized, double-blind, placebo-controlled trial of the efficacy of fluoxetine in improving functional recovery after acute stroke (2014-2018, CIB)
- NHMRC funded Head Position in Stroke Trial (HeadPoST) (2014-2017, CIA)
- NHMRC funded Family-Led Rehabilitation after Stroke in India: The ATTEND trial (2013-2016, CIF)
- UK Stroke Association funded Fluoxetine or Control Under Supervision (FOCUS): a start-up randomised controlled trial (2011-2015, CIJ)
- Maree was the principal investigator on the completed NHMRC funded Psychosocial Outcomes in Stroke - POISE study.